Friday, February 13

Healthcare

GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD

09/07/20241 Min Read

COPD disorder GSKs latestage lung Nucala study succeeds

Previous ArticleAxogen completes marketing submission for Avance Nerve Graft

Next Article Travere gains on full FDA approval for kidney drug Filspari